Trials / Conditions / Adenocarcinomas of the Gastroesophageal Junction

Adenocarcinomas of the Gastroesophageal Junction

3 registered clinical trials studyying Adenocarcinomas of the Gastroesophageal Junction.

Status	Trial	Sponsor	Phase
Terminated	Panitumumab, Paclitaxel, Carboplatin and 5FU in the Treatment of Potentially Resectable Gastroesophageal Adeno NCT01182610	Accelerated Community Oncology Research Network	Phase 2
Completed	Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have F NCT01129206	Ohio State University Comprehensive Cancer Center	Phase 2
Terminated	Pharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation. NCT00216008	H. Lee Moffitt Cancer Center and Research Institute	Phase 2